Results 151 to 160 of about 10,988 (206)

Oncolytic HSV1716 attenuates tumor-killing activity of infected primary NK cells. [PDF]

Front Immunol
Susek KH, Holla D, Marsal C, Kashif M, Albert J, Flore V, Gilljam M, Karvouni M, Meinke S, Wagner AK, Powers C, Allen R, Alici E.   +12 more
europepmc   +1 more source

Harnessing natural RNA triplex elements found in lncRNAs MALAT1 and NEAT1 for engineering of novel riboswitch platforms. [PDF]

Nucleic Acids Res
Gommeringer P, Müller E, Köse S, Kayser L, Leber MF, Ungerechts G, Nettelbeck DM, Hartig JS.   +7 more
europepmc   +1 more source

Cracking the shield: oncolytic viruses versus the tumor-immune fortress. [PDF]

Cancer Cell Int
El-Derby AM, Salem NT, Hesham N, Salem TZ.   +3 more
europepmc   +1 more source

Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation. [PDF]

Virulence
Zhao X, Zhang H, Xu S, Mei L, Feng Z, Wang D, Huang W, Shen Y.   +7 more
europepmc   +1 more source

Gamma-irradiated Newcastle disease virus: an alternative inactivated oncolytic virotherapy. [PDF]

Immunol Cell Biol
Kennedy EV, Chuah Y, Mostafa AH, Gates CJ, Foeng J, Norton TS, McColl SR, Comerford I, Davies JB, Hemmatzadeh F, Alsharifi M.   +10 more
europepmc   +1 more source

Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8⁺ T cells. [PDF]

Commun Med (Lond)
Kong L, Liu K, Liu Y, Cui H, Wang P, Qiu J, Xin Q, Zhou D, Liu W, Zhao F, Wu J, Gu X, Wu J, Jiang C.   +13 more
europepmc   +1 more source

Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis. [PDF]

J Immunother Cancer
Gomez-Manzano C, Shin DH, Alvarez-Breckenridge C, Gillard AG, Morad G, Puduvalli VK, Alonso MM, Lang FF, Fueyo J.   +8 more
europepmc   +1 more source

Combination of CIK cells with oncolytic viruses: A potential Immunovirotherapy strategy for the treatment of solid tumors. [PDF]

Transl Oncol
Parvinzad Leilan M, Arianejad M, Omidi Sarajar B, Tavoosidana G.   +3 more
europepmc   +1 more source

Antitumor activity of Oncolytic Herpes Symplex Virus Type 1 and photodynamic therapy in in vitro preclinical models of glioblastoma. [PDF]

J Transl Med
Calistri A, Rossetto A, Reale A, Fornaini MV, Panarelli M, Persano L, Rampazzo E, Parolin C, Donati V, de Oliveira do Rêgo AG, Di Pietro C, Marazziti D, Mammano F.   +12 more
europepmc   +1 more source

Strategically engineering an oncolytic herpes simplex virus to improve systemic delivery. [PDF]

Mol Ther Oncol
Fu X, Benedyk T, Zhang SX.
europepmc   +1 more source